ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

RAD Radiopharm Theranostics Limited

0.035
0.00 (0.00%)
May 22 2024 - Closed
Delayed by 20 minutes

Radiopharm Theranostics Financial Summary

The current RAD market cap is 15.38M. The company's latest EPS is AUD -0.0788 and P/E is -0.38.

Year End June 29 2023 202120222023
AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 09k6.21M
Operating Income -484k-19.92M-33.81M
Net Income -485k-30.42M-34.61M
Year End June 29 2023 202120222023
AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 33k83.38M74.95M
Total Liabilities 158k20.42M29.37M
Total Equity -125k62.96M45.58M

Cash Flow

Year End June 29 2023 202120222023
AUD (AUD)AUD (AUD)AUD (AUD)
Operating -33k-9.91M-23.2M
Investing N/A -28.38M-1.53M
Financing 60k65.11M9.22M
Market Cap 15.38M
Price to Earnings Ratio -0.38
Price to Sales Ratio 2.13
Price to Cash Ratio 1.13
Price to Book Ratio 0.29
Dividend Yield -

Share Statistics

Shares Outstanding 439.36M
Average Volume (1 week) 336.1k
Average Volume (1 Month) 466.72k
52 Week Change -78.13%
52 Week High 0.16
52 Week Low 0.035
Spread (Intraday) 0 (2.86%)

Company Info

Company Name Radiopharm Theranostics Limited
Address level 3
melbourne, victoria 3053
Website https://www.radiopharmtheranostics.com
Industry in vitro,in vivo diagnostics (2835)

Your Recent History

Delayed Upgrade Clock